Cryoport has Been Engaged by Roslin Cells for Logistics Support of Roslin’s iPSC service

March 31, 2015

Lake Forest, CA, March 31, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been engaged to provide its cryogenic logistics services to Roslin Cells of Edinburgh, United Kingdom in support of Roslin’s induced pluripotent stem cell  (iPSC) reprogramming service.

Read More

Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cancer, Roslin, iPSC, pluripotent stem cell, reprogramming